|
CD 40 CD 40L与血栓性疾病研究进展 |
| |
bsp;GK , et al. CD 40 ligation induces tissue factor expression in human vascular smooth muscle cells[ J ].Am J Pathol, 2000 (1):7 14.
[4]BABENDIEK U, LIBBY P, KILBRIDEM, et al. Induction of tissue factor expression in human endothrlial cells by CD 40 ligand is mediated via activator protein 1, nucler factor kappa B, and Egr 1 [ J ]. J Biol Chem, 2002, 277 (28):2503225039.
[5]VIALLARD JF, SOLANILLA A, GAUTHIER B, et al . Increased soluble and Plateletassociated CD 40 ligand in essential thrombocythemia and reactive thrombocytosis[J] . Blood , 2002 ,99(7):2612 2614.
[6]LUTGENS E,CLEUTIENS KB,HEENMAN S,et al. Both early and delayed antiCD 40L antibody treatment induces a stable plaque phenotype [J]. Proc Natl Acad Sci USA ,2000 ,97:74647469.
[7]WU L , FAN J , MATSUMOTO I , et al . Induction and regulation of matrix metalloproteinase12 by cytokines and CD 40 signaling in monocyte/ macrophages[J ] . Biochem Biochem Biophys Res Commun , 2000,269:808815.
[8]缪宇锋, 张润玲,李光迪. 急性脑缺血及脑梗死患者外周血单核细胞 CD 40L的表达与变化对病情及预后的评估作用. 中国临床康复2005,5(9):106107.
[9]GARLICHS CD, KOZINA S, TOMANDL, et al. Upregulation of上一页 [1] [2] [3] [4] [5] [6] [7] 下一页
上一个医学论文： C反应蛋白及其多态性与冠心病
下一个医学论文： 抗凝血酶治疗弥散性血管内凝血的研究进展
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文